Inari Medical Inc [NARI] stock is trading at $48.74, up 0.70%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The NARI shares have gain 11.53% over the last week, with a monthly amount glided 17.14%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Inari Medical Inc [NASDAQ: NARI] stock has seen the most recent analyst activity on September 18, 2024, when Stifel initiated its Hold rating and assigned the stock a price target of $50. Previously, Leerink Partners started tracking the stock with Market Perform rating on September 03, 2024, and set its price target to $47. On August 09, 2024, Deutsche Bank initiated with a Buy rating and assigned a price target of $68 on the stock. William Blair started tracking the stock assigning a Outperform rating. Needham downgraded its rating to a Hold. Piper Sandler downgraded its rating to Neutral for this stock on February 29, 2024, and downed its price target to $55. In a note dated January 23, 2024, Needham initiated an Buy rating and provided a target price of $72 on this stock.
Inari Medical Inc [NARI] stock has fluctuated between $36.73 and $67.13 over the past year. Currently, Wall Street analysts expect the stock to reach $66.11 within the next 12 months. Inari Medical Inc [NASDAQ: NARI] shares were valued at $48.74 at the most recent close of the market. An investor can expect a potential return of 35.64% based on the average NARI price forecast.
Analyzing the NARI fundamentals
Inari Medical Inc [NASDAQ:NARI] reported sales of 574.50M for the trailing twelve months, which represents a growth of 21.39%. Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at -0.08%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.14%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.18 and Total Capital is -0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 48.30 points at the first support level, and at 47.86 for the second support level. However, for the 1st resistance point, the stock is sitting at 49.05, and for the 2nd resistance point, it is at 49.36.
Ratios To Look Out For
For context, Inari Medical Inc’s Current Ratio is 1.77. In addition, the Quick Ratio stands at 1.40 and the Cash Ratio stands at 0.28. Considering the valuation of this stock, the price to sales ratio is 5.00, the price to book ratio is 6.55.
Transactions by insiders
Recent insider trading involved Hykes Andrew, President and CEO, that happened on Oct 29 ’24 when 3000.0 shares were sold. Director, Hoffman William completed a deal on Oct 29 ’24 to sell 40000.0 shares. Meanwhile, Director ANDREW J HYKES bought 9000.0 shares on Oct 29 ’24.
